Institute for Precision Health | University of Leicester

You currently have JavaScript disabled in your web browser, please enable JavaScript to view our website as intended.

Multiple test tubes in a holder

Our Research Institutes

Institute for Precision Health

The Institute for Precision Health is a joint venture between the University and University Hospitals of Leicester. Our vision is to enhance Leicester’s reputation as an international centre of excellence in precision health, uncovering disease mechanisms, developing novel diagnostics and therapies and translating them for patient and societal benefit.

With over £40 million of competitively won funding secured annually for health-related research and the excellence of our Clinical Medicine research acknowledged in REF2021, the Institute for Precision Health is ideally placed to facilitate world-leading clinical research across our priority areas.

Contact us

Dr Lynne Howells (room 341) Office (room 342) Lab (room 344)
Maurice Shock Medical Sciences (MSB)
University of Leicester
University Road
Leicester
LE1 7RH
UK

iph@le.ac.uk
+44 (0)116 252 5174
Follow us on Twitter and LinkedIn

About the Institute

Research areas

Projects

Partnerships

We work with local, national and international organisations to deliver effective results.

Publications

People

Research opportunities

Shorts, Sounds and Writes

IPH Events

The Institute for Precision Health offers numerous opportunities to take part in events including, showcasing research, industrial collaborations, development of research partnerships, networking, and public engagement. We are proud to support our PhD student cohort, and welcome suggestions for further events that help to champion early career researcher aspirations.

See our upcoming and past events

Leicester Drug Discovery and Diagnostics (LD3)

LD3 supports translational research across the Colleges, providing research and commercialisation expertise underpinned by pump-prime funding opportunities from sequential MRC IAA awards. This allows researchers to accelerate the development of medicines, therapies, diagnostic tests and devices that have ‘real world benefit’ for patients.

Learn more about LD3